IFP Advisors, Inc - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2021$12,000
+50.0%
1,463
+58.5%
0.00%
Q1 2021$8,000
+14.3%
923
+16.1%
0.00%
Q4 2020$7,000
-41.7%
795
-39.8%
0.00%
-100.0%
Q3 2020$12,0001,3200.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$00
-100.0%
0.00%
Q2 2018$020.0%0.00%
Q1 2018$020.0%0.00%
Q4 2017$020.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders